Objective. Preeclampsia has been associated with elevated proinflammatory markers, increased sympathetic activity, and decreased plasma volume (PV). We hypothesized that these associations would be identified in women prior to a first pregnancy. Methods. We studied 76 healthy nulligravid participants measuring the proinflammatory markers C-reactive protein (CRP), interleukin-6 (IL-6), and tumor necrosis factor a (TNF-a). Plasma volume was measured in supine position and corrected for body mass index (BMI). We examined supine plasma levels of epinephrine and norepinephrine and blood pressure response to Valsalva maneuver to quantify sympathetic activation. We then examined the association of PV and sympathetic activity with proinflammatory cytokines with P < .05 accepted for significance. Results. CRP was significantly increased in participants with lowest PV/BMI quartile when compared to middle 2 quartiles and highest quartile (analysis of variance [ANOVA], P ¼ .037). We found no significant association of PV/BMI with either IL-6 or TNF-a. Both plasma epinephrine concentration (r ¼ .29, P ¼ .02) and the late phase II (phase II_L) blood pressure response to Valsalva maneuver (r ¼ .44, P < .0001) were associated with serum IL-6 concentrations. Conclusions. Low PV is associated with increased CRP levels and increased sympathetic tone is linked to elevated IL-6 concentration in young nonpregnant women. These findings represent elements of a nonpregnancy phenotype that parallels the findings observed in preeclampsia and in women at risk for ischemic cardiovascular disease. This suggests that the relationships observed during preeclampsia, which have been associated with placental pathology, may predate pregnancy and be independent of placental activity.
INTRODUCTION
Preeclampsia is a pregnancy-specific disorder characterized by hypertension and proteinuria that occurs in the second half of pregnancy. 1 It is a leading cause of maternal and fetal morbidity and mortality and occurs most often in nulliparous patients. The exact etiology is unclear, but the disorder has been associated with decreased maternal plasma volume (PV) and increased sympathetic tone. [2] [3] [4] [5] [6] [7] [8] In addition, there is evidence to support an association between preeclampsia and inflammatory cytokines. 9, 10 Patients who develop preeclampsia during pregnancy are at increased risk of long-term cardiovascular complications, such as ischemic cardiovascular disease, thromboembolic disease, and chronic hypertension. [11] [12] [13] [14] These diseases, most specifically ischemic cardiovascular disease, appear to be associated with elevations of inflammatory cytokines. 15, 16 This suggests a common thread of underlying physiologic factors that may predispose to the development of these diseases.
We have hypothesized that preeclampsia can result from an intolerance to the normal volume expansion of pregnancy in some women with a specific prepregnancy phenotype. 17 We have suggested that reduced PV is at the core of this prepregnancy phenotype and we have demonstrated, in young healthy women who have never been pregnant, that low PV is associated with increased sympathetic tone and exaggerated platelet activation, 18, 19 findings that are associated with both preeclampsia and long-term cardiovascular risk. 20, 21 In strong support of this hypothesis, a group of investigators from Maastricht has recently demonstrated that PV between pregnancies, in women who had preeclampsia in their first pregnancy, is a predictor of pregnancy complications in future pregnancies. 22, 23 Most recently, their results suggest that interpregnancy PV in those with prior preeclampsia completely discriminated future pregnancy hypertensive complications of pregnancy. 24 In their observations, all women with low interpregnancy PV went on to develop recurrent hypertensive disease of pregnancy, while those with higher interpregnancy PVs did not.
In this study, we sought to determine the relationship between levels of the inflammatory cytokines C-reactive protein (CRP), interleukin-6 (IL-6), and tumor necrosis factor a (TNF-a), all of which are increased in women with preeclampsia, with sympathetic tone and PV in nulligravid women of reproductive age. We hypothesized that the association between low PV, elevated sympathetic tone, and increased inflammatory cytokines observed in women with preeclampsia would exist as a cohort phenotype prior to pregnancy supporting an expanded view of prepregnancy phenotypes and their relationship to the clinical laboratory associations observed in women with preeclampsia.
MATERIAL AND METHODS
A total of 76 nulligravid women of reproductive age were recruited for participation in this study through an open enrollment. The study participants were between the ages of 18 and 40 years, nonsmokers, free from major medical illness including cardiovascular disease or diabetes mellitus, and taking no regular drugs or medications other than thyroid replacement. All participants were studied in the fasting state. They were asked to abstain from alcohol and caffeine for at least 24 hours prior to the study and to avoid the use of decongestants and nonsteroidal medications for at least 48 hours prior to the study. All studies were performed during the follicular phase of the menstrual cycle. On the morning of study, women were questioned and were free of either recent (72 hours) or current illness and all women were afebrile and had normal vital signs at admission.
Each study began at about 7:00 AM. Participants were admitted to the University of Vermont General Clinical Research Center following an overnight fast. A firstvoid urine was obtained for a pregnancy test. In addition, height and weight were obtained to calculate body mass index (BMI). The participant was placed in supine position. An 18-gauge intravenous saline lock was placed in the antecubital vein for blood draws and administration of dye. After 30 minutes at rest in supine position, a discard blood sample was drawn to clear the indwelling line and the blood immediately surrounding the catheter. Blood was then drawn without venous constriction for measurement of CRP (mg/L), IL-6 (pg/mL), and TNF-a (pg/mL) concentrations. In addition, a superficial forearm vein was catheterized and the hand and forearm placed in a warming box set at 50 C to ''arterialize'' the venous samples. 25 After at least 15 minutes in the warming box blood samples for plasma catecholamine assessment were obtained from the indwelling catheter without occlusion. Blood samples were collected in pre-iced tubes and immediately spun with plasma analyzed for free catecholamines (epinephrine, norepinephrine) using a 2-step chromatographic purification method that results in a highly purified and concentrated final eluate. 26 The purified amines were then quantified using high-pressure liquid chromatography with electrochemical detection. C-reactive protein was measured using the BNII nephelometer from Dade Behring using a particleenhanced immunonepholometric assay. Polystyrene particles are coated with monoclonal antibodies to CRP, which, in the presence of antigen (CRP) agglutinate to cause an increase in the intensity of scattered light. The assay range is 0.16 to 1100 ug/mL. Interassay CVs range from 2.1% to 5.7%. Interleukin-6 was measured by ultrasensitive enzyme-linked-immunosorbent serologic assay (ELISA; R&D Systems, Minneapolis, MN). The lower detection limit <0.15 pg/mL, detection range 0.156 to 10.0 pg/mL. We have determined a routine interassay coefficient of variation (CV) of 15%. TNF-a is measured by an ultrasensitive, solid-phase sandwich ELISA using a monoclonal antibody specific for TNF-a (R&D Systems). The lower detection limit is 0.18 pg/mL with a detection range of 0.5 to 32 pg/mL. Using this method, we have determined a routine interassay CV of 18%.
Plasma volume was estimated in supine position using the Evans blue dye dilution test. A 15 mg dose of Evans blue dye was administered, using a preweighed syringe, over a 1-minute period through the saline lock. The Evans blue dye was prepared as a batched sample for this project. Samples for measurement of baseline plasma values had already been drawn, and additional plasma samples were drawn at 10 and 30 minutes after the dye injection to measure disappearance kinetics and calculate PV. Samples were placed in a centrifuge for 30 minutes, and the supernatant plasma was collected. Dye from the samples was absorbed into a sephadex chromatographic column, read with a spectrophotometer at 615 nm absorption, and compared to a standardized solution of Evans blue dye. A log transformed decay line was generated from the 10 and 30 minute postdosing samples, and extrapolated back to calculate PV, a technique described in further detail elsewhere. 27, 28 The PV was reported in total mL, and as plasma volume per body mass index (PV/BMI), to control for variations in body size.
Continuous noninvasive tonometric radial artery blood pressure monitoring was performed employing the Colin Pilot 9200 device (San Antonio, TX) with autostandardization to brachial artery measurements. Heart rate/RR interval measurements were obtained by a standard 3-lead electrocardiogram integrated with blood pressure measurements via the Colin device. Baseline blood pressure and heart rate were estimated following 30 minutes of supine rest by calculating the mean arterial pressure and RR interval from measurements during a sample time window. Sympathetic responsiveness was estimated by measuring the blood pressure response to Valsalva maneuver in the supine position. 29 Participants created a forced expiration for 20 seconds against a nonfixed low flow resistance to a pressure of 40 millimeters of mercury measured with an attached manometer. The calculated difference between the peak mean arterial pressure measured at the end of late phase II response of the Valsalva maneuver and the trough mean arterial pressure at the end of the early phase II response is termed the late phase II (phase II_L) response and reflects baroreceptor activity mediated by vascular a-adrenergic receptors. 29 Additional elements of this technique have been previously outlined. 19 Data are expressed as mean + standard deviation (SD). Regression analyses were performed where appropriate. P < .05 was considered significant. Statistical analysis was performed using SigmaStat software (Version 2.0, Chicago, IL). The University of Vermont Committee on Human Research approved this study. All participants provided written informed consent prior to participation in this study.
RESULTS
At the time of study, participants were 26.1 + 4.8 years, at menstrual cycle day 10.5 + 2.0 days, and the mean BMI was 23.4 + 3.2 kg/m 2 . Participants were predominantly Caucasian (73/76, 96%). The mean values for the physiologic observations are presented in Table 1 .
For purposes of comparison, the relationship of PV to inflammatory cytokines participants were divided into quartiles, based upon PV/BMI. This data is presented in Table 2 . Examining the relationship between PV and inflammatory cytokines using analysis of variance (ANOVA), we found a significant difference between quartiles of CRP (P ¼ .037). The mean CRP from the lowest PV/BMI quartile was significantly elevated when compared to the middle 2 quartiles (P < .05). In contrast to this, we identified no significant relationship of IL-6 or TNF-a to PV corrected for BMI. We examined the cross correlation of CRP, IL-6, and TNF-a in these samples. C-reactive protein was strongly associated with IL-6 (r ¼ .40, P < .001) but was not associated with TNF-a (r ¼ -.05, P ¼ .65). We observed no association of IL-6 with TNF-a (r ¼ .14, P ¼ .24). The independent relationship of BMI to CRP was evaluated to determine whether it was the relationship of body size to CRP that defined the significant association of PV/BMI to CRP. In our relatively fit sample of participants with an average BMI of approximately 23, there was no significant association of BMI to CRP (r ¼ .12, P ¼ .29) We did observe a significant direct association of BMI to PV (r ¼ .23, P ¼ .04).
Despite its negative association with PV, we found that CRP was not significantly correlated with any index of sympathetic tone (Table 3 ). However, IL-6 was associated with phase II_L response to Valsalva and there was a trend toward an association with plasma epinephrine concentration. Consistent with these observations, there was also an inverse relationship of IL-6 with the cardiac RR interval, but the strength of this relationship fell short of significance (P ¼ .06). In support of our prior observations, there was a significant negative association of PV to Phase II-L Valsalva response, an index of a adrenergic responsiveness, and with heart rate. The R value for this relationship is -.31, P ¼ .006 for phase II_L response and R ¼ .35, P < .002 for heart rate expressed as RR interval.
DISCUSSION
We have broadly hypothesized that some women develop preeclampsia based in part on their prepregnancy physiology. Specifically, we have suggested that chronic low prepregnancy PV results in the inability to accommodate the profound physiologic volume expansion of pregnancy. 17 Plasma volume is decreased in women with preeclampsia, and there is strong evidence this reduction in PV precedes the clinical manifestations of disease. Aardenburg has recently demonstrated that PV following a pregnancy complicated by preeclampsia strongly predicts recurrent hypertensive complications of pregnancy. 24 Evidence also suggests that women who develop preeclampsia during pregnancy, particularly those with preterm preeclampsia, appear to be at increased risk for cardiovascular disease later in life. [12] [13] [14] This raises the intriguing possibility that elements of the preeclampsia syndrome share pathophysiologic characteristics with cardiovascular disease and raises the possibility of a shared physiologic predisposition with reduced PV as a component.
Elevated levels of proinflammatory cytokines have been identified in patients with preeclampsia. 9,10 These cytokines have been observed to be elevated prior to the onset of clinical symptoms of preeclampsia. 30 Some have speculated the increased proinflammatory cytokine environment contributes to abnormal placentation and plays a role in placental ischemia which results in release of molecules capable of inducing oxidative injury, most specifically endothelial cell damage. However, it is still unclear exactly how early in pregnancy the elevation of inflammatory cytokines observed with preeclampsia occurs, and whether it might even precede the pregnancy. It also remains unclear what role these inflammatory cytokines play as active mediators of placental dysfunction or the pathophysiology of preeclampsia.
In this study, we sought to determine whether elevated serum proinflammatory cytokines, a finding common to both preeclamptic and ischemic cardiovascular syndromes, were linked to either reduced PV or elevated sympathetic tone in young healthy nulligravid women of reproductive age. We have previously demonstrated that prior to pregnancy reduced PV is associated with increased sympathetic tone, an observation that has been confirmed by other investigators. 19, 31 Our findings demonstrate that CRP levels in the lowest PV quartile were elevated when compared to the middle PV quartiles. Those women with the lowest PV had the highest CRP levels. This suggests there is a biologic subset of nulligravid women with decreased PV and elevated CRP. Elevated levels of CRP are associated with risk for ischemic cardiovascular disease. [32] [33] [34] C-reactive protein levels have even been demonstrated to affect the arteries of children by disrupting endothelial function and promoting early atherosclerotic change. 35 Thus, elevated levels of CRP may be a common element found in association with endothelial injury in both the preeclampsia syndrome and atherosclerotic cardiovascular disease.
Sympathetic tone is difficult to quantify and our measures are subject to limitations. The measurement of catecholamines, such as epinephrine, is influenced by synaptic transmitter release and reuptake, neural activity, target receptor density and sensitivity, and blood flow. Regional variations may not be detectable with peripheral blood measurements. Nevertheless, we did identify trends associating plasma epinephrine with serum concentration of both TNF-a and IL-6. Valsalva maneuver provides information about the integration of cardiac and peripheral vascular adrenergic function, but may not be sensitive to the detection of regional variations in cardiovascular adaptation. This may limit information regarding the adaptation in regional beds of interest in preeclampsia including the kidney and uterus. We did, however, demonstrate a strong association of the phase II_L a adrenergically mediated blood pressure response to Valsalva maneuver with serum levels of IL-6, suggesting a global association of sympathetic responsiveness with the serum concentration of a proinflammatory cytokine.
We believe our findings contribute to the hypothesis that a prepregnancy phenotype exists that combines many of the subclinical elements of the preeclampsia syndrome.
These associations support the concept of a common underlying phenotype contributing to both the development of preeclampsia and the long-term risks of ischemic cardiovascular disease as the elements of platelet activation, increased sympathetic tone, and elevated proinflammatory cytokines are common to both and are linked before a first pregnancy. 36, 37 
